US2001A
(en)
*
|
|
1841-03-12 |
|
Sawmill |
US2215233A
(en)
|
1937-11-13 |
1940-09-17 |
Simon L Ruskin |
Iron compound of nucleotides and their organic hydrolytic decomposition products and method of making same
|
US3906092A
(en)
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
US3911117A
(en)
|
1971-12-20 |
1975-10-07 |
Fredrik Ender |
Raw fish and iron chelated with glutamic or ribonucleic acid in a mink diet
|
US3914450A
(en)
|
1973-04-09 |
1975-10-21 |
Anheuser Busch |
Concentrated extract of yeast and processes of making same
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
US5023243A
(en)
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
ATE75483T1
(de)
|
1981-10-23 |
1992-05-15 |
Molecular Biosystems Inc |
Oligonukleotides heilmittel und dessen herstellungsverfahren.
|
ES507187A0
(es)
|
1981-11-16 |
1983-01-01 |
Union Ind Y Agro Ganader S A U |
Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
|
JPS60126220A
(ja)
|
1983-12-09 |
1985-07-05 |
Otsuka Pharmaceut Factory Inc |
核酸成分組成物
|
US4741914A
(en)
|
1984-11-13 |
1988-05-03 |
Ajinomoto Co., Inc. |
Flavor enhancing seasoning containing deodorized garlic extract and process
|
US4956296A
(en)
|
1987-06-19 |
1990-09-11 |
Genex Corporation |
Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
|
JPS62275667A
(ja)
|
1986-05-22 |
1987-11-30 |
Ajinomoto Co Inc |
こく味調味料又はこく味の増強された食品の製造法
|
DK273888A
(da)
|
1987-05-20 |
1988-11-21 |
Chugai Pharmaceutical Co Ltd |
Salterstatning og krydderier med et indhold deraf
|
ES2007350A6
(es)
|
1987-05-29 |
1989-06-16 |
Ganadera Union Ind Agro |
Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
|
JP2656571B2
(ja)
*
|
1987-11-17 |
1997-09-24 |
三井東圧化学株式会社 |
テトラフェニルチオフェン誘導体およびこれを含有する電子写真用感光体
|
US5268365A
(en)
|
1988-03-11 |
1993-12-07 |
Rudolph Frederick B |
Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
|
CA1336174C
(en)
|
1988-07-22 |
1995-07-04 |
Ronald Peter Potman |
Method for the preparation of a yeast extract said yeast extract, its use as a food flavour and a food composition comprising the yeast extract
|
US5231085A
(en)
|
1988-10-31 |
1993-07-27 |
Sandoz Ltd. |
Compositions and methods for the enhancement of host defense mechanisms
|
US5786189A
(en)
|
1989-11-29 |
1998-07-28 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine
|
US5248670A
(en)
|
1990-02-26 |
1993-09-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides for inhibiting herpesviruses
|
US5514577A
(en)
|
1990-02-26 |
1996-05-07 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide therapies for modulating the effects of herpes viruses
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
US5234811A
(en)
|
1991-09-27 |
1993-08-10 |
The Scripps Research Institute |
Assay for a new gaucher disease mutation
|
JPH06509704A
(ja)
|
1991-04-18 |
1994-11-02 |
ザ ソールク インスチチュート フォア バイオロジカル スタディズ |
特定dna配列に選択的に結合する蛋白質に対する偽構築体として有用なオリゴデオキシヌクレオチドおよびオリゴヌクレオチド
|
US6022853A
(en)
|
1991-08-30 |
2000-02-08 |
Creative Biomolecules, Inc. |
Morphogen-enriched dietary composition
|
WO1993017115A2
(en)
|
1992-02-18 |
1993-09-02 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
Dysentery vaccine stimulating an immune response against shigatoxin, plasmids and host strains for it
|
DE69333433T2
(de)
|
1992-04-01 |
2004-12-02 |
The Rockefeller University |
Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
|
EP0572735B1
(de)
|
1992-06-04 |
1998-11-25 |
VYSIS, Inc. |
Nukleinsäuresonden zum Nachweis von Mycoplasma fermentans
|
US5585479A
(en)
|
1992-07-24 |
1996-12-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human ELAM-I RNA
|
KR950704482A
(ko)
|
1992-10-05 |
1995-11-20 |
다알렌 반스톤 |
치료용 항-hiv 올리고누클레오티드 및 이것을 함유하는 약제학적 제형(therapeutic anti-hiv oligonucleotide and pharmaceutical)
|
US5650156A
(en)
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
WO1995001097A1
(en)
|
1993-06-30 |
1995-01-12 |
Board Of Regents, The University Of Texas System |
Nucleotide preparation and uses thereof in wound healing
|
US5849719A
(en)
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
US5804566A
(en)
|
1993-08-26 |
1998-09-08 |
The Regents Of The University Of California |
Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
|
GB9326425D0
(en)
|
1993-12-24 |
1994-02-23 |
Secr Defence |
Vaccine compositions
|
US5700590A
(en)
|
1994-01-10 |
1997-12-23 |
Abbott Laboratories |
Nutritional formula with ribo-nucleotides
|
US5488039A
(en)
|
1994-01-10 |
1996-01-30 |
Abbott Laboratories |
Method for the production of an enteral formula containing ribo-nucleotides
|
US5492899A
(en)
|
1994-01-10 |
1996-02-20 |
Abbott Laboratories |
Infant nutritional formula with ribo-nucleotides
|
US5602109A
(en)
|
1994-01-10 |
1997-02-11 |
Abbott Laboratories |
Method to enhance the immune system of a human
|
DE69517836T2
(de)
|
1994-03-18 |
2001-03-01 |
Ajinomoto Kk |
Proteinhaltiges Mittel zur Verbesserung der Geschmacksqualität von Lebensmitteln
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6194388B1
(en)
|
1994-07-15 |
2001-02-27 |
The University Of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5591721A
(en)
|
1994-10-25 |
1997-01-07 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
US6428788B1
(en)
|
1995-03-15 |
2002-08-06 |
Penn State University |
Compositions and methods for specifically targeting tumors
|
US5614191A
(en)
|
1995-03-15 |
1997-03-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
JP3580900B2
(ja)
|
1995-04-20 |
2004-10-27 |
ホクレン農業協同組合連合会 |
α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料
|
US5612060A
(en)
|
1995-05-25 |
1997-03-18 |
Alexander; J. Wesley |
Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy
|
US5976580A
(en)
|
1995-06-07 |
1999-11-02 |
Novus International, Inc. |
Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
|
GB9525902D0
(en)
|
1995-12-16 |
1996-02-21 |
Zeneca Ltd |
Fungus
|
EP0879284B1
(de)
|
1996-01-30 |
2009-07-29 |
The Regents of The University of California |
Expressionsvektoren, die eine antigen-spezifische immunantwort induzieren, und methoden für ihre verwendung.
|
US5895652A
(en)
|
1996-07-29 |
1999-04-20 |
Longevity Institute International |
Method of metabolic adjuvanation and cellular repair
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
JP4111403B2
(ja)
|
1996-10-11 |
2008-07-02 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
免疫刺激ポリヌクレオチド/免疫調節分子複合体
|
EP0855184A1
(de)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmazeutisches Präparat das ein Polynukleotid und ein Antigen enthält, insbesondere zur Impfung
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
DK1005368T3
(da)
*
|
1997-03-10 |
2010-01-04 |
Ottawa Hospital Res Inst |
Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer
|
US6426334B1
(en)
*
|
1997-04-30 |
2002-07-30 |
Hybridon, Inc. |
Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
|
WO1998052581A1
(en)
*
|
1997-05-20 |
1998-11-26 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
ATE432348T1
(de)
*
|
1997-06-06 |
2009-06-15 |
Univ California |
Inhibitoren von immunstimulatorischen dna sequenz aktivität
|
US5922766A
(en)
|
1997-07-02 |
1999-07-13 |
Acosta; Phyllis J. B. |
Palatable elemental medical food
|
JP4663113B2
(ja)
|
1997-09-05 |
2011-03-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
抗原刺激顆粒球媒介炎症を予防または軽減するための免疫刺激オリゴヌクレオチドの使用
|
US6218371B1
(en)
*
|
1998-04-03 |
2001-04-17 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
EP1075520A1
(de)
|
1998-05-06 |
2001-02-14 |
PHARMACIA & UPJOHN COMPANY |
Einführung der nackten dns oder rns die für nicht-menschliche peptide hormone oder zytokine kodieren in ein nicht-menschliches wirbeltier
|
EP1077708A1
(de)
*
|
1998-05-06 |
2001-02-28 |
University Of Iowa Research Foundation |
Methoden zur preventiven und therapeutischen behandlung von parasitären infektionen und damit verbundener krankheiten mittels cpg oligonukleotiden
|
ATE305507T1
(de)
*
|
1998-05-14 |
2005-10-15 |
Coley Pharm Gmbh |
Verfahren zur regulierung der hematopoiese mit hilfe von cpg oligonukleotide
|
PT1733735T
(pt)
|
1998-05-22 |
2017-06-16 |
Ottawa Hospital Res Inst |
Métodos e produtos para induzir imunidade mucosal
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
JP2002521489A
(ja)
|
1998-07-27 |
2002-07-16 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
CpGオリゴヌクレオチドの立体異性体および関連する方法
|
US20010034330A1
(en)
|
1998-08-10 |
2001-10-25 |
Charlotte Kensil |
Innate immunity-stimulating compositions of CpG and saponin and methods thereof
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
EP1832657B1
(de)
|
1998-09-09 |
2012-10-24 |
Genzyme Corporation |
Methylierung von Plasmid-Vektoren
|
US20020142974A1
(en)
|
1998-09-11 |
2002-10-03 |
Leonard D. Kohn |
Immune activation by double-stranded polynucleotides
|
AU776288B2
(en)
|
1998-10-05 |
2004-09-02 |
Regents Of The University Of California, The |
Methods and adjuvants for stimulating mucosal immunity
|
EP1117433A1
(de)
|
1998-10-09 |
2001-07-25 |
Dynavax Technologies Corporation |
Anti hiv zusammensetzungen, die immunstimulierende polynukleotide und hiv antigene enthalten
|
WO2000042856A1
(en)
|
1999-01-22 |
2000-07-27 |
The Schepens Eye Research Institute, Inc. |
Activation of regulatory t cells by alpha-melanocyte stimulating hormone
|
US6977245B2
(en)
*
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
AU4343700A
(en)
*
|
1999-04-12 |
2000-11-14 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Oligodeoxynucleotide and its use to induce an immune response
|
WO2000062787A1
(en)
|
1999-04-15 |
2000-10-26 |
The Regents Of The University Of California |
Methods and compositions for use in potentiating antigen presentation by antigen presenting cells
|
EP1177439B1
(de)
|
1999-04-29 |
2004-09-08 |
Coley Pharmaceutical GmbH |
Screening nach modulatoren der funktion von immunstimulatorischer dna
|
ES2250151T3
(es)
|
1999-06-29 |
2006-04-16 |
Glaxosmithkline Biologicals S.A. |
Uso de cpg como adyuvante de vacuna contra vih.
|
US6514948B1
(en)
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
CA2380947C
(en)
|
1999-08-19 |
2011-11-01 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
EP1221955B9
(de)
*
|
1999-09-25 |
2005-11-30 |
University Of Iowa Research Foundation |
Immunstimulierende nukeinsäuren
|
NZ517928A
(en)
|
1999-09-27 |
2004-09-24 |
Coley Pharm Gmbh |
Methods related to immunostimulatory nucleic acid-induced interferon
|
US6949520B1
(en)
*
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
US20020091095A1
(en)
|
1999-12-13 |
2002-07-11 |
Phillips Nigel C. |
Modulation of Fas and FasL expression
|
US20020006403A1
(en)
|
1999-12-14 |
2002-01-17 |
Xue-Zhong Yu |
CD28-specific antibody compositions for use in methods of immunosuppression
|
ATE378348T1
(de)
*
|
2000-01-14 |
2007-11-15 |
Us Health |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
AU3108001A
(en)
|
2000-01-20 |
2001-12-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
WO2001055341A2
(en)
|
2000-01-31 |
2001-08-02 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
WO2001062207A2
(en)
|
2000-02-23 |
2001-08-30 |
The Regents Of The University Of California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
US6423539B2
(en)
|
2000-02-24 |
2002-07-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adjuvant treatment by in vivo activation of dendritic cells
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US20020107212A1
(en)
|
2000-03-10 |
2002-08-08 |
Nest Gary Van |
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US20010046967A1
(en)
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
US20020028784A1
(en)
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
US6534062B2
(en)
|
2000-03-28 |
2003-03-18 |
The Regents Of The University Of California |
Methods for increasing a cytotoxic T lymphocyte response in vivo
|
WO2001076642A1
(en)
|
2000-04-07 |
2001-10-18 |
The Regents Of The University Of California |
Synergistic improvements to polynucleotide vaccines
|
JP2004530629A
(ja)
*
|
2000-06-07 |
2004-10-07 |
バイオシネクサス インコーポレーテッド |
免疫刺激rna/dnaハイブリッド分子
|
US20020165178A1
(en)
|
2000-06-28 |
2002-11-07 |
Christian Schetter |
Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia
|
EP1322328B1
(de)
|
2000-07-27 |
2014-08-20 |
Children's Hospital & Research Center at Oakland |
Impfstoffe zum breitbandschutz gegen von neisseria meningitidis verursachten krankheiten
|
US20020198165A1
(en)
|
2000-08-01 |
2002-12-26 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of gastric ulcers
|
US7811592B2
(en)
|
2000-08-16 |
2010-10-12 |
Auburn University |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
|
US20020091097A1
(en)
|
2000-09-07 |
2002-07-11 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of sexually transmitted diseases
|
EP1322656B1
(de)
|
2000-09-26 |
2008-01-16 |
Idera Pharmaceuticals, Inc. |
Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen
|
EP1322292B1
(de)
|
2000-09-28 |
2007-01-03 |
Novartis Vaccines and Diagnostics, Inc. |
Mikropartikelzusammensetzungen und verfahren zu ihrer herstellung
|
WO2002034887A2
(en)
|
2000-10-24 |
2002-05-02 |
Schering Corporation |
Maturation of dendritic cells
|
KR100331952B1
(ko)
|
2000-11-23 |
2002-04-09 |
최수일 |
다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과 비특이 면역증강제로서의 용도
|
US7666674B2
(en)
*
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
WO2003020884A2
(en)
*
|
2001-08-14 |
2003-03-13 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Method for rapid generation of mature dendritic cells
|
AU2002366710A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
US8043622B2
(en)
*
|
2002-10-08 |
2011-10-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
|
AU2003304107B2
(en)
*
|
2002-11-01 |
2008-05-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
|
JP2008523084A
(ja)
*
|
2004-12-08 |
2008-07-03 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫賦活用合剤および方法
|
WO2006065751A2
(en)
*
|
2004-12-13 |
2006-06-22 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
US7892569B2
(en)
*
|
2005-08-31 |
2011-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods of altering an immune response induced by CpG oligodeoxynucleotides
|
US8053422B2
(en)
*
|
2008-12-04 |
2011-11-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-cancer oligodeoxynucleotides
|